Enhancing opioid therapy for chronic pain with buprenorphine, counseling, and brain stimulation
Treatments studied
Part of Pain clinical trials.
This study is testing whether adding a medication (buprenorphine), counseling, and a type of brain stimulation (TMS) can improve long-term opioid therapy for chronic pain. If you have been taking prescription opioids daily for at least 3 months and have extra risk factors for opioid-related problems, this trial may offer you new ways to manage pain and reduce risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and speak English.
- You have taken prescription opioid pain medication daily for at least 3 months.
- Your current daily opioid dose is equivalent to at least 20 mg of morphine.
- You have at least one additional risk factor, such as taking benzodiazepines, having a history of overdose, or experiencing poor pain relief from opioids.
- You do not have serious health conditions that would make participation unsafe (like unstable heart disease, certain mental health conditions, or pregnancy).
- You are not currently taking methadone, buprenorphine, or naltrexone.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a non-invasive brain stimulation approach to reduce opioid cravings in people who are actively using non-prescribed opioids while on stable methadone. It may help people feel less craving and improve recovery support.
This study tests a sleep improvement program to help people with chronic widespread pain reduce or stop their opioid pain medication. If you want to cut back on opioids and have trouble sleeping, this treatment might be a good fit.
This trial tests if brain stimulation can help people starting buprenorphine for opioid use disorder. It aims to improve treatment outcomes and support recovery.
This study tests a non-invasive brain stimulation technique called TMS to see if it can reduce opioid cravings and help people who are already taking buprenorphine stay in recovery. TMS uses magnetic pulses to stimulate parts of the brain involved in addiction.
This Phase 1 study tests how adding psilocybin to a standard opioid treatment (buprenorphine-naloxone) affects recovery and symptoms in people with moderate-to-severe opioid use disorder. It may help researchers understand whether this combination is safe and beneficial alongside medication for opioid withdrawal and cravings.
This study tests a new type of brain stimulation that adapts to your brain activity, aiming to reduce cravings and help you control opioid use. It is for people with long-standing opioid use disorder who have not gotten lasting relief from at least 3 treatment attempts, including medication.
Hear when a new Opioid Withdrawal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.